The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of mirvetuximab soravtansine (MIRV) and gemcitabine (G) in patients (Pts) with selected frα-positive solid tumors: Results in the ovarian cancer (EC) cohort.
 
Mihaela C. Cristea
Honoraria - Abbvie; AstraZeneca
Consulting or Advisory Role - Abbvie; AstraZeneca
Speakers' Bureau - AstraZeneca
 
Nora H. Ruel
No Relationships to Disclose
 
Paul Henry Frankel
No Relationships to Disclose
 
Timothy W. Synold
No Relationships to Disclose
 
Daphne B. Stewart
No Relationships to Disclose
 
Edward Wenge Wang
No Relationships to Disclose
 
Alex Jung
No Relationships to Disclose
 
Sharon Wilczynski
No Relationships to Disclose
 
Michael Tran
No Relationships to Disclose
 
Gottfried E. Konecny
Speakers' Bureau - AstraZeneca; Clovis Oncology; Merck; Tesaro
Research Funding - Lilly (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Novartis
 
Melissa Eng
Stock and Other Ownership Interests - Medtronic
 
Lindsay Kilpatrick
No Relationships to Disclose
 
Yi-Jen Chen
No Relationships to Disclose
 
Scott Glaser
Employment - City of Hope
Honoraria - Reflexion Medical
Consulting or Advisory Role - Elsevier
 
Thanh Hue Dellinger
No Relationships to Disclose
 
Amy Hakim
No Relationships to Disclose
 
Stephen Lee
No Relationships to Disclose
 
Robert Morgan
No Relationships to Disclose
 
Ernest Soyoung Han
No Relationships to Disclose